Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2017 | short review

Short review San Antonio 2016

Surgical therapies for breast cancer

verfasst von: Michael Hubalek, MD, PhD, Theresa Czech, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Summary

The San Antonio Breast Cancer Symposium 2016 featured all areas in the treatment of breast cancer. However, the meeting again showed that surgery remains the major column in the treatment of breast cancer. Various areas of development in the surgical management of breast cancer received significant attention in 2016 – sentinel lymph node (SLN) biopsy after neoadjuvant chemotherapy, radiotherapy after breast reconstruction and imaging strategies for the surgical treatment of breast cancer. In this short overview the most interesting presentations from the meeting are presented.
Vorheriger Artikel SABCS 2016: systemic therapy for metastatic breast cancer
Nächster Artikel Distinct computed tomography features of non-small-cell lung cancer in a European population with EML4-ALK translocation
Literatur
1.
2.
Classe J‑M, Loaec C, Alran S, Paillocher N, Tunon-Lara C, Gimbergues P, Faure-Virelizier C, Chauvet M‑P, Lasry S, Dupre P‑F, Verhaeghe J‑L, De Blaye P, Gutowski M, Barranger E, Lecuru F, Lefevre Lacoeuille C, Loussert L, Lambaudie E, Ferron G, Campion L. Sentinel node detection after Neoadjuvant chemotherapy in patient without previous axillary node involvement (GANEA 2 trial): follow-up of a prospective multi-institutional cohort. Presented at: 2016 San Antonio Breast Cancer Symposium, Abstract S2–07, San Antonio, 6–10 December 2016. 2016.
3.
Lyman GH, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2016;35(5):561–4. doi:10.​1200/​jco.​2016.​71.​0947.CrossRef
4.
Unkart JTT, Chen SLL, González JEE, Harootunian A, Wallace AMM. Intraoperative tumor detection using a ratiometric activatable fluorescent peptide: a first-in-human phase I study allows tumors to be visualized in the operating room. Presented at: 2016 San Antonio Breast Cancer Symposium, Abstract PD3–02, San Antonio, 6–10 December 2016. 2016.
5.
Langhans L, Tvedskov TF, Klausen TL, Jensen M‑B, Talman M‑L, Vejborg I, Benian C, Roslind A, Hermansen J, Oturai PS, Bentzon N, Kroman N. Radioactive seed localization versus wire guided localization of nonpalpable invasive and in situ breast cancer: a Danish multicenter randomized controlled trial. Presented at: 2016 San Antonio Breast Cancer Symposium, Abstract S3–08, San Antonio, 6–10 December 2016. 2016.
6.
Jagsi R, Momoh AOO, Qi J, Hamill JBB, Billig J, Kim HMM, Pusic ALL, Wilkins EGG. Impact of radiotherapy on complications and patient-reported satisfaction with breast reconstruction: findings from the prospective multicenter MROC study. Presented at: 2016 San Antonio Breast Cancer Symposium, Abstract S3–07, San Antonio, 6–10 December 2016. 2016.
7.
Recht A, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. Ann Surg Oncol. 2017;24(1):38–51. doi:10.​1245/​s10434-016-5558-8.CrossRefPubMed
8.
Lai S‑F, et al. Locoregional recurrence risk for postmastectomy breast cancer patients with T1-2 and one to three positive lymph nodes receiving modern systemic treatment without radiotherapy. Ann Surg Oncol. 2016; doi:10.​1245/​s10434-016-5435-5.
9.
10.
McDermott M, Wilson C, Xu J, Illmann C, Simmons C. Does MRI influence surgical planning more than clinical outcome? A cohort study of breast cancer patients receiving neoadjuvant therapy. Presented at: 2016 San Antonio Breast Cancer Symposium, Abstract P3–02–05, San Antonio, 6–10 December 2016. 2016.
Metadaten
Titel
Short review San Antonio 2016
Surgical therapies for breast cancer
verfasst von
Michael Hubalek, MD, PhD
Theresa Czech, MD
Publikationsdatum
01.06.2017
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0331-7

Weitere Artikel der Ausgabe 2/2017

Notes from California – experts review the ASH meeting 2016 in San Diego

  • editorial

Is there progress in the treatment of high-risk myeloma?

  • short review

American Society of Hematology 2016 annual meeting

  • short review

American Society of Hematology 2016 annual meeting

  • review

Brentuximab vedotin in a patient with enteropathy-associated T‑cell lymphoma of the small bowel

  • case report

Hematopoietic stem cell transplantation: up-date from ASH 2016

  • short review